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INTRODUCTION
The classification of marijuana regardless of whether it is for medical or recreational use is a Schedule 1 drug under the Controlled Substances Act (CSA).1
Medical research on the positive effects of marijuana and the shift towards acceptance of marijuana opened the floodgates for states legalizing marijuana for
medical use.2 A majority of states have enacted medical marijuana laws that permit the growth, use, and distribution of marijuana for medical purposes, as well
as licensing patients to buy and use marijuana.3 However, although these marijuana laws are legal under state laws, they nonetheless conflict with federal law.
The Rohrabacher-Farr Amendment (RFA), prohibits the federal government
from using funds “to prevent states from implementing their own [state] laws
that authorize the use, possession, distribution, or cultivation of marijuana.”4
This paper examines the RFA and its relation to the cases decided in the
Ninth Circuit and other courts, to determine whether there is a trend towards one
line of thinking or another. Part I looks at the history of the RFA and discusses
the impact from the conflict between state and federal laws and the appropriate
roles for the states and the federal government in setting drug policy. Parts II and
III examine the role played by the Department Of Justice (DOJ) in its evolving
policy pronouncement in shaping the marijuana debate in the states. Part IV assesses the role of case law under the Ninth Circuit, exploring whether it is trite
for Congress to reschedule the CSA to conform to the prevailing reality as dictated by the states or to simply formulate a method as already set forth by the
DOJ whereby states will have the option to opt out of CSA. Part V looks at the
possible federal marijuana reforms as well as the proposed Marijuana Act of
1.
21 U.S.C. § 841(a)(1) (2010) (meaning the CSA criminalizes marijuana as a controlled substance and consequently, it is illegal to sell, “manufacture, distribute, or dispense”
the drug in any form).
2.
See Bill Greenberg & Rebecca Greenberg, 26 USC Section 280E: Will the Dragon
Now Be Slayed?, 25 J.L. & POL. 549, 563, 566 (2017) (“In the 45 years since the CSA’s enactment, extensive research evidence has emerged demonstrating that cannabis has demonstrably beneficial palliative effects for the treatment of a myriad group of medical
pathologies . . . .”).
3.
Thirty-three states, Guam, Puerto Rico and the District of Columbia currently have
laws permitting marijuana for medical use, while ten states and the District of Columbia have
adopted laws legalizing marijuana for recreational use. State Medical Marijuana Laws, NSCL
(Nov. 8, 2018), http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx; Marijuana Overview, NSCL (Nov. 13, 2018), http://www.ncsl.org/research/civil-and-criminaljustice/marijuana-overview.aspx.
4.
See Patricia H. Heer, Rohrabacher-Blumenauer Amendment On Hold; FinCen
Guidance Reviewed; and Cole Memo Rescinded, DUANE MORRIS BLOGS (Jan. 20, 2018),
http://blogs.duanemorris.com/cannabis/2018/01/20/rohrabacher-blumenauer-amendment-onhold-fincen-guidance-reviewed-and-cole-memo-rescinded/#more-241.
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2017. Part VI discusses whether if rescheduling is possible, will it fix the state—
federal conflict over marijuana and probes into some problems that may be presented by continuing federal prosecution of businesses and individuals/patients;
specifically the banking and tax connundrums.
I.

HISTORY OF THE ROHRABACHER-FARR AMENDMENT

Congressman Maurice Hinchey originally introduced the RFA to the House
of Representatives in 2003, who rejected it by a 152-273 vote.5 The amendment
was reintroduced for several years following the initial introduction, but the
House continued rejecting it each time.6 Finally, after being reintroduced again
in 2014, the House passed it with a 219-189 vote.7 The amendment was approved
for the 2016 fiscal year.8 Congressman Hinchey originally introduced the amendment in an effort to protect medical marijuana patients who were in compliance
with their state laws.9 The congressman felt that taxpayer’s dollars were being
wasted by sending seriously or terminally ill patients to jail and believed that
states’ rights should prevail.10 Representative Dana Rohrabacher believed that
the passage of this provision would allow states to provide their citizens access
to medical marijuana without the fear of being prosecuted.11
Under the RFA, the DOJ is precluded from using funds to prosecute individuals and businesses that are in violation of the CSA, so long as those individuals
comply with their states’ medical marijuana regulations.12
5.
Final Vote Results For Roll Call 420, OFF. CLERK: U.S. HOUSE REPRESENTATIVES
(July 23, 2003, 2:56 PM), http://clerk.house.gov/evs/2003/roll420.xml.
6.
See, e.g., Final Vote Results For Roll Call 334, OFF. CLERK: U.S. HOUSE
REPRESENTATIVES (July 7, 2004, 11:05 PM), http://clerk.house.gov/evs/2004/roll334.xml;
Final Vote Results For Roll Call 255, OFF. CLERK: U.S. HOUSE REPRESENTATIVES (June 15,
2005, 2:51 PM), http://clerk.house.gov/evs/2005/roll255.xml; Final Vote Results For Roll
Call 333, OFF. CLERK: U.S. HOUSE REPRESENTATIVES (June 28, 2006, 5:35 PM), http://clerk.
house.gov/evs/2006/roll333.xml.
7.
Final Vote Results For Roll Call 258, OFF CLERK: U.S. HOUSE REPRESENTATIVES
(May 30, 2014, 12:22 AM), http://clerk.house.gov/evs/2014/roll258.xml.
8.
See Final Vote Results For Roll Call 283, OFF. CLERK: U.S. HOUSE REPRESENTATIVES (June 3, 2015, 2:20 PM), http://clerk.house.gov/evs/2015/roll283.xml.
9.
House Votes 264-161 Against Hinchey Medical Marijuana Amendment,
PROCON.ORG, http://medicalmarijuana.procon.org/view.resource.php?resourceID=000869
(last updated Apr. 9, 2008, 9:56 AM).
10. Id.
11. Press Release, Rohrabacher Hails Passage of Medical Marijuana Amendment
(June 4, 2015), https://rohrabacher.house.gov/media-center/press-releases/rohrabacher-hailspassage-of-medical-marijuana-amendment.
12. H.R. 2578, 114th Cong. (2015) (“None of the funds made available in this Act to
the Department of Justice may be used, with respect to any of the States of Alabama, Alaska,
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The biggest issue with the amendment arises from the language of the
amendment itself, as it seems to be open for interpretation. The DOJ reads the
amendment narrowly, contending that it prevents actions against the state, not
against individuals and businesses within the state.13 The Ninth Circuit, the largest federal circuit, has numerous states which have legalized medical marijuana.14 As such, it is appropriate to review cases from this circuit to see if the
interpretation of the DOJ is consistent with case law.
Proponents believe that the intent of the amendment is clear, however, case
law shows that the DOJ has continued to prosecute patients and businesses.15 In
April 2015, representatives Rohrabacher and Farr sent a letter to then Attorney
General Eric Holder, addressing comments made by DOJ spokesman, Patrick
Rodenbush.16 In a Los Angeles Times article, Rodenbush said the amendment
did not apply to cases against individuals or organizations, and that it only
stopped the “department from impeding the ability of states to carry out their
medical marijuana laws.”17 The letter goes on to express that states are best suited
to investigate state violations and should be free from federal interference.18 After considering several cases challenging the DOJ’s prosecution of medical marijuana growers, the Ninth Circuit, in United States v. McIntosh recently held

Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois,
Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York,
North Carolina, Oklahoma, Oregon, Rhode Island, South Carolina, Tennessee, Texas, Utah,
Vermont, Virginia, Washington, and Wisconsin, or with respect to either the District of Columbia or Guam, to prevent any of them from implementing their own laws that authorize the
use, distribution, possession, or cultivation of medical marijuana.”).
13. Christopher Ingraham, Federal court tells the DEA to stop harassing medical marijuana providers, WASH. POST (Oct. 20, 2015), https://www.washingtonpost.com/news/wonk
/wp/2015/10/20/federal-court-tells-the-dea-to-stop-harassing-medical-marijuana-providers/?
utm_term=.6b52b9d660c2.
14. State Marijuana Laws in 2018 Map, GOVERNING, https://www.washingtonpost.
com/news/wonk/wp/2015/10/20/federal-court-tells-the-dea-to-stop-harassing-medical-marijuana-providers/?utm_term=.6b52b9d660c2 (last updated Nov. 7, 2018) (showing that Washington, Idaho, Hawaii, Alaska, Nevada, Oregon, California, and Montana have all legalized
marijuana in some way).
15. See Press Release, supra note 11.
16. Letter from Dana Rohrabacher & Sam Farr, Members of Cong., to Eric Holder,
Att’y Gen. of the U.S. (April 8, 2015); Press Release, supra note 11.
17. Timothy M. Phelps, Justice Department says it can still prosecute medical marijuana cases, L.A. TIMES (Apr. 2, 2015, 3:00 AM), http://www.latimes.com/nation/nation
now/la-na-nn-medical-marijuana-abusers-20150401-story.html.
18. Letter from Dana Rohrabacher & Sam Farr, supra note 16.
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that, where the defendants are in compliance with state laws, federal law prohibits their prosecution.19 In United States v. Chavez, the Defendant, James Chavez,
filed a motion to dismiss a marijuana possession charge in which he allegedly
had 118 plants in his possession while on federal land.20 Chavez contended that
the charge should be dismissed based on the amendment.21 The Ninth Circuit
court denied Chavez’s motion to dismiss, stating that the amendment did not
repeal federal laws criminalizing possession of marijuana nor did the amendment
suggest that Congress intended to affect the federal government’s exercise of
police powers over federal land.22 The court recognized the tension created from
the amendment but found the defendant’s argument unpersuasive.23 The court
stated: “[i]f Congress intended to legalize the possession of marijuana under federal law, they could have repealed or amended the CSA to accomplish that goal
in a straightforward manner.”24
II.

MARIJUANA POLICY AND THE DOJ UNDER PRESIDENT
TRUMP’S ADMINISTRATION

Previously, under the Obama Administration, Deputy Attorney General
James Cole sent a memorandum (the Cole Memo) to all United States Attorneys
addressing federal prosecution in states who have voted to legalize marijuana.25
The Cole Memo discusses eight priorities for the federal government and the
need for the DOJ to use its resources effectively.26

19. United States v. McIntosh, 833 F.3d 1163, 1169, 1178 (9th Cir. 2016).
20. United States v. Chavez, No. 2:15-cr-210-KJN, 2016 WL 916324 (E.D. Cal.
Mar. 10, 2016) at *1–2.
21. Id. at *1. Defendant Chavez submitted paperwork showing that his medical condition warranted “cultivation of up to 99 plants and possession of up to 11 pounds of usable
marijuana.” Id. at *2. However, the government alleged and the defendant’s attorney agreed,
the defendant was in possession of 118 plants which exceeds the amount he was permitted. Id.
22. Id. at *1–2.
23. Id. at *1.
24. Id. (quoting United States v. Tote, No. 1:14-mj-00212-SAB, 2015 WL 3732010,
at *2 (E.D. Cal. June 12, 2015)).
25. Memorandum from James M. Cole, Deputy Att’y Gen. on Guidance Regarding
Marijuana Enforcement (Aug. 29, 2013) https://www.justice.gov/iso/opa/resources/3052013
829132756857467.pdf.
26. Id. at 1–2 (explainaing that the DOJ is to focus its efforts on eight priority enforcement areas considered paramount to the federal government, which include: “[p]reventing the distribution of marijuana to minors; preventing revenue from the sale of marijuana
from going to criminal enterprises, gangs, and cartels; preventing the diversion of marijuana
from states where it is legal under state law in some form to other states; preventing stateauthorized marijuana activity from being used as a cover or pretext for the trafficking of other
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In April of 2016, while still under the Obama administration, the Senate
Caucus on International Narcotics Control held a hearing entitled “Is the Department Protecting the Public from the Impact of State Recreational Marijuana Legalization?”27 At this Senate hearing, then Senator Sessions stated, “[w]e need
grown-ups in charge in Washington to say marijuana is not the kind of thing that
ought to be legalized, it ought not to be minimized, that it’s in fact a very real
danger.”28 Sessions went on to say, “Colorado was one of the leading states that
started the movement to suggest that marijuana is not dangerous and we’re going
to see more marijuana use and it’s not going to be good.”29 Sessions mentioned
that one of President Obama’s great failures was his lax treatment and comments
on marijuana, stating “[i]t reverses 20 years . . . of hostility to drugs . . . [which
began] when Nancy Reagan began the Just Say No program.”30
Since this hearing in 2016, President Trump appointed Jeff Sessions as Attorney General.31 In a memo sent out in April, Sessions asked the Justice Department task force to review policies on marijuana and requested recommendations
“no later than July 27th.”32 Steven Cook, a federal prosecutor who is said to have
taken a “hard line on sentencing reform and liberalizing drug rules,” is one who
has been tasked with reviewing policies.33
In May of 2017, Sessions sent a letter asking congressional leaders to undo
protections set in place by the RFA.34 Sessions argued in his letter that this

illegal drugs or other illegal activity; preventing violence and the use of firearms in the cultivation and distribution of marijuana; preventing drugged driving and the exacerbation of other
adverse public health consequences associated with marijuana use; preventing the growing of
marijuana on public lands and the attendant public safety and environmental dangers posed by
marijuana production on public lands; and preventing marijuana possession or use on federal
property.”).
27. Is the Department of Justice Adequately Protecting the Public from the Impact of
State Recreational Marijuana Legalization?, S. CAUCUS ON INT’L NARCOTICS CONTROL
(Apr. 5, 2016), http://www.drugcaucus.senate.gov/content/departent-justice-adequately-pro
tecting-public-impact-state-recreational-marijuana.
28. U.S. Senate Drug Caucus, Protecting the Public from the Impact of State Recreational Marijuana Legalization, YOUTUBE (Apr. 5, 2016), https://www.youtube.com/watch
?time_continue=22&v=gg0bZvIS0K8.
29. Id.
30. Id.
31. See Trump cabinet: Senate confirms Jeff Sessions as attorney general, BBC NEWS
(Feb. 9, 2017), http://www.bbc. com/news/world-us-canada-38915273.
32. Eli Watkins, Pot activists have been holding their breath for months on Jeff
Sessions, CNN, http://www.cnn.com/ 2017/06/17/politics/jeff-sessions-marijuana/index.html
(last updated June 17, 2017, 8:35 AM).
33. Id.
34. Christopher Ingraham, Jeff Sessions personally asked congress to let him prosecute medical-marijuana providers, WASH. POST (June 13, 2017), http://www.washington
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amendment “inhibits the [DOJ’s] authority to enforce the Controlled Substances
Act.”35 Sessions stated we are in the midst of a “historic drug epidemic” and the
DOJ should be in a position “to use all laws available to combat” this epidemic.36
In Session’s May 2017 letter, he mentioned that the Ninth Circuit Court of
Appeals interpreted the Rohrabacher-Farr provision broadly, citing United States
v. McIntosh.37 Sessions went on to say, “in the Ninth Circuit, many individuals
and organizations that are operating in violation of the CSA and causing harm in
their communities may invoke the rider to thwart prosecution.”38 Sessions argued
individuals who are involved in criminal organizations have established marijuana operations in state-approved marijuana markets.39 These individuals find a
place within state regulatory systems.40 Sessions uses the example of a recent
raid in Denver that led to the confiscation of more than 2,500 pounds of marijuana and the indictment of sixteen people.41 The Chief of the Drug Enforcement
Agency (DEA) in Denver said that people move to Colorado “with the expressed
purpose of hiding their illicit proceeds and their illicit activities in plain sight
under some of the laws that we have.”42
The Rohrabacher-Farr provisions, which were considered marijuana protections have been extended through September 30, 2017.43 Although the provision
was extended, President Trump attached a signed statement saying, “I will treat
this provision consistently with my responsibility to take care that the laws be
faithfully executed.”44 According to a contributor for the Washington Post, prior
post.com/news/wonk/wp/2017/06/13/jeff-sessions-personally-asked-congress-to-let-him-pro
secute-medical-marijuana-providers/?utm_term=.43fff2ca65b8.
35. Id.
36. Id.
37. Letter from Jefferson B. Sessions III, U.S. Att’y Gen., to Congress (May 1, 2017),
https://www.jennifermcgrath.com/wp-content/uploads/Jeff-Sessions-Letter-Medical-Mariju
ana-5.1.2017.pdf.
38. Tom Angell, Exclusive: Sessions Asks Congress To Undo Medical Marijuana Protections, MASSROOTS (June 12, 2017), http://www.massroots.com/news/exclusive-sessionsasks-congress-to-undo-medical-marijuana-protections.
39. Letter from Jefferson B. Sessions III, supra note 37.
40. Id.
41. Id.
42. Jesse Paul, 16 people indicted in massive home-grown marijuana operation across
Denver area, DENVER POST (Mar. 17, 2017, 5:34 PM), http://www.denverpost.com/2017/03/
17/marijuana-grow-operation-denver-metro-area/.
43. Zach Harris, A Brief History of Rohrabacher-Farr: The Federal Amendment Protecting Medical Marijuana, MERRY JANE (Dec 19, 2017), https://merryjane.com/news/a-briefhistory-of-rohrabacher-farr-the-federal-amendment-protecting-medical-marijuana.
44. Jeremy Berke, Trump indicated where he stands on medical marijuana for the first
time since he took office, BUS. INSIDER (May 6, 2017, 12:15 AM), http://www.business
insider.com/medical-marijuana-trump-administration-2017-first-statement-2017-5?op=1.
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presidents have used similar statements to “ignore or undermine polices they disagree with.”45
III. THE CHANGING ADMINISTRATION’S STANCE ON THE
ISSUE OF MARIJUANA LEGALIZATION
In July 2016, a reporter asked President Trump his thoughts on Governor
Chris Christie’s remarks that he would use federal funding to shut down sales of
recreational marijuana in states like Colorado.46 President Trump responded that
the decision should be left up to the states, calling himself a “states person.”47 In
a letter addressed to President Trump, California Lieutenant Governor Gavin
Newsom urged the President to stick to his campaign commitment of “honoring
states’ rights when it comes to marijuana legalization.”48 President Trump has
not always been consistent on the issue of medical marijuana.49 He has been
known to support states’ rights to choose how to legislate marijuana and has also
simply said that the legal marijuana industry is a real problem.50
During a White House briefing in February 2017, then White House press
secretary, Sean Spicer stated he expected “states to be subject to ‘greater enforcement’ of federal laws against marijuana use.”51 Spicer went on to say that the
Trump Administration does recognize a difference between medical marijuana
and marijuana for recreational use.52
Recently, at a Senate appropriations committee meeting in June 2017, Deputy Attorney General Rod Rosenstein alluded to changes being made as to how

45. Christopher Ingraham, It took Jeff Sessions just one month to turn Obama-era drug
policy on its head, WASH. POST (June 2, 2017), https://www.washingtonpost.com/news/wonk
/wp/2017/06/02/it-took-jeff-sessions-just-one-month-to-turn-obama-era-drug-policy-on-itshead/?utm_term=.09c5a54995aa.
46. Brent Johnson, Does Trump disagree with Christie on marijuana?, N.J. POL.
(Jul. 30, 2016), https://www.nj.com/politics/index.ssf/2016/07/does_trump_disagree_with_
christie_on_marijuana.html.
47. Id.
48. Letter from Gavin Newsom, Cal. Lieutenant Governor, to Donald J. Trump, President of the U.S. (Feb. 24, 2017), http://ltg.ca.gov/documents/PresidentTrump22417.pdf.
49. Kris Krane, Why President Trump Is Positioned To Be Marijuana’s Great Savior
& How The Democrats Blew It, FORBES (July 11, 2018, 6:00 AM), https://www.forbes.com/
sites/kriskrane/2018/07/11/why-president-trump-could-be-marijuanassavior/#79ad366620a0.
50. See id.
51. John Wagner & Matt Zapotsky, Spicer: Feds could step up enforcement against
marijuana use in states, WASH. POST (Feb. 23, 2017), http://www.washingtonpost.com/news/
post-politics/wp/2017/02/23/spicer-feds-could-step-up-anti-pot-enforcement-in-states-whererecreational-marijuana-is-legal/?utm_term=.0f1fe04c8350.
52. Id.
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the DOJ will handle enforcement in states that have legalized marijuana.53 At
this meeting Rosenstein stated, “[w]e follow the law and the science. From a
legal and scientific perspective, marijuana is an unlawful drug.”54
On January 4, 2018, the DOJ issued a memo in which Attorney General Sessions reiterated to U.S. Attorney Generals to enforce the law relating to the prosecution of marijuana and its related activities as enacted by Congress.55 That is,
Attorney General Sessions was explicitly reversing the 2013 Cole Memo of the
Obama administration on Marijuana prosecution. The 2018 Sessions memo
stated in part that:
“It is the mission of the Department of Justice to enforce the laws of the
United States, and the previous issuance of guidance undermines the
rule of law and the ability of our local, state, tribal, and federal law enforcement partners to carry out this mission,” said Attorney General Jeff
Sessions. “Therefore, today’s memo on federal marijuana enforcement
simply directs all U.S. Attorneys to use previously established prosecutorial principles that provide them all the necessary tools to disrupt criminal organizations, tackle the growing drug crisis, and thwart violent
crime across our country.”56
This memo rescinds multiple guidance documents issued during the Obama administration, such as the Cole Memo, which provided that when US attorneys
decide on how to spend their resources on marijuana crimes, they should focus
on certain high priority areas, such as the sale of marijuana to children-not on
prosecuting people who were complying with their own states laws.57 As such,
the hands-off approach of the Obama administration is apparently over. The
more fundamental questions are where does this leave the states that have legalized medical marijuana? Which way does the court lean in this debate?

53. Andrea Noble, Changes forthcoming for DOJ on marijuana, Deputy AG Rosestein
hints, WASH. TIMES (June 13, 2017), http://www.washingtontimes.com/news/2017/jun/13/rod
-rosenstein-hints-changes-doj-marijuana/.
54. Id.
55. Press Release, Jefferson B. Sessions, Attorney Gen., Marijuana Enforcement
(Jan. 4, 2018), https://www.justice.gov/opa/press-release/file/1022196/download.
56. Press Release, Dep’t of Justice, Justice Department Issues Memo on Marijuana
Enfforcement (Jan. 4, 2018) (on file with Dep’t of Justice).
57. See Memorandum from James M. Cole, supra note 25.
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IV. THE ROLE OF CASE LAW IN THE MARIJUANA DEBATE—
THE NINTH CIRCUIT’S CONTRIBUTION
To understand the evolution and different rationales of the courts’ decisions
surrounding this legal debate looking at cases beginning in 2016 is helpful.
A. U.S. v. McIntosh58
McIntosh, a landmark decision of the Ninth Circuit, discussed 10 cases seeking consolidated interlocutory appeals and petitions for writs of mandamus.59
These cases challenged the DOJ prosecution of medical marijuana cases that
arose from orders entered by courts in California and Washington.60 The appellants were charged with violations of federal narcotic laws although in compliance with their states’ laws.61 The appellants “moved to dismiss their indictments
or to enjoin their prosecutions on the grounds that the Department of Justice
(DOJ) [was] prohibited from spending funds to prosecute them.”62
In one of the cases addressed by McIntosh, five codefendants operated four
marijuana stores in Los Angeles and nine indoor marijuana grow sites in San
Francisco and Los Angeles.63 Amongst conspiracy to manufacture charges, the
codefendants were also indicted with intent to distribute more than 1,000 marijuana plants.64 The DOJ sought forfeiture.65
In another case discussed by McIntosh, Lovan, the DEA and the Fresno
County Sheriff’s Office located more than 30,000 marijuana plants on a sixtyacre property.66 “Four codefendants were indicted for manufacturing” over 1,000
marijuana plants.67
While in Kynaston, a search warrant was issued which led to the discovery
of 562 growing marijuana plants and 677 pots.68 Five codefendants were charged
and indicted amongst other charges, for conspiracy to manufacture over 1000
marijuana plants.69

58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.

United States v. McIntosh, 833 F.3d 1163 (9th Cir. 2016).
See id. at 1168.
Id. at n.1.
See id. at 1168–69.
Id. at 1169.
McIntosh, 833 F.3d at 1169.
Id.
Id.
Id.
McIntosh, 833 F.3d at 1169.
Id.
Id.
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Based on the appropriations rider, appellants in McIntosh, Lovan, and
Kynaston collectively filed a motion to dismiss or enjoin.70 The issue presented
in the three previously mentioned cases, was whether the Appropriations Act
prohibited the DOJ from using funds to prevent states from implementing medical marijuana laws and to prosecute defendants for federal marijuana offenses.71
The court held that the appellants had standing to enjoin the DOJ from
spending federal funds to prosecute them for federal marijuana offenses.72 The
DOJ violated the Appropriations Act by spending federal funds to prevent states
from implementing the entirety of their medical marijuana laws.73 The court’s
rational was that the Appropriations Act prohibits the DOJ from preventing states
from implementing their medical marijuana laws.74 That “[b]y officially permitting certain conduct, state laws provide for non-prosecution of individuals who
engage in such conduct. If federal government prosecutes such individuals, it has
prevented the state from giving practical effect to its law providing for non-prosecution of individuals who engage in the permitted conduct.”75 Further, the court
noted while the Appropriations Act prohibits the federal government from using
funds to prevent states from implementing laws, the DOJ may still prosecute
individuals who engage in conduct which violates state laws.76 Moreover, if the
DOJ wishes to continue with the prosecution, then the appellants are entitled to
evidentiary hearings which will determine whether their conduct was authorized
by state law, and the DOJ may proceed from there.77
It is worth noting that the appellants in McIntosh and Kynaston argued for a
more expansive interpretation of the Appropriations Act.78 The appellants argued
the Appropriations Act prohibited the DOJ from bringing federal charges
“against anyone licensed or authorized under state medical marijuana law for
activity occurring within that state . . . .”79 Appellants stated that prosecution by
the DOJ will prohibit states from enforcing penalties which will in turn prevent
states from implementing the entirety of their laws.80 According to appellants,
unless the activity is clearly outside the scope of the state’s laws, the DOJ should

70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.

Id. at 1170.
McIntosh, 833 F.3d at 1169.
Id. at 1173.
Id. at 1176.
Id.
Id. at 1176–77.
Id. at 1177–78.
McIntosh, 833 F.3d at 1179.
Id. at 1177.
Id.
Id.
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refrain from prosecuting.81 The court recognized the desire for a more expansive
interpretation but only considered the text of the rider.82 The court stated that it
is Congress’ responsibility to expand or minimize the intent of the Appro-priations Act by providing clarity.83
Ultimately, the enforcement of the CSA “is estopped in the Medical Marijuana States when those who would be prosecuted are in compliance with their
state laws.”84
B. Mann v. Gullickson85
Although this case was a motion for summary judgment in a breach of contract claim and does not involve the DOJ per se, it did discuss the Appropriations
Act and the direction the courts may be headed in.86
In this case, Mann, the plaintiff, sold two businesses to Gullickson, the defendant, for a specified amount to be paid in installments.87 The businesses were
consulting businesses for state-regulated marijuana licenses and an online marijuana retail operation.88 Gullickson failed to make payments and Mann filed an
action for breach of contract claim.89 Gullickson filed a cross complaint.90 Gullickson asserted that the agreement was void because it related to medical marijuana which is a prohibited substance under the federal controlled substances act
even if legal in the states where the companies operate.91
The court mentioned that the government gave conflicting signals related to
marijuana regulation.92 The court also stated that “where a party challenges enforcement of a contract based on the defense of illegality under federal law,” it
must be addressed whether to apply state or federal law.93The court further discussed that “where contracts concern illegal objects, [if] it is possible for the

81.
82.
83.
84.
(2016).
85.
86.
87.
88.
89.
90.
91.
92.
93.

Id.
McIntosh, 833 F.3d at 1178–79.
Id. at 1179.
Robert L. Greenberg, Medical Marijuana Post-McIntosh, 20 CUNY L. REV. 46, 49
Mann v. Gullickson, No. 15-cv-03630-MEJ, 2016 WL 6473215 (N.D. Cal. 2016).
Id. at *4.
Id. at *1.
Id.
Id.
Id. at *2.
Mann, 2016 WL 6473215, at *2.
See id. at *4.
Id. at *5.
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court to enforce a contract in a way that does not require illegal conduct,” the
court may do so.94
Gullickson contended that since the contracts were for marijuana businesses
and enforcement would be mandating illegal conduct, the court is prohibited
from enforcing the contract.95 While the court found no merit to this claim, the
court did state that to avoid unjust enrichment to a defendant and a harsh penalty
to the plaintiff, even if the object of the agreement were illegal, the contract
would still be enforced.96 That “[e]nforcing the contract in this case is not endorsing the cultivation, possession, or distribution of marijuana.”97 The court
therefore denied Gullickson’s motion for summary judgment.98
C. U.S. v. Kleinman99
In the recent case United States v. Kleinman, the Defendant, Noah Kleinman,
appealed his jury conviction and sentence for “conspiracy to distribute and possess marijuana, distribution of marijuana, maintaining drug-involved premises,
and conspiracy to commit money laundering.”100 Kleinman operated a marijuana
storefront which he alleged complied with California state law, and which the
government alleged was a conspiracy to distribute marijuana.101 He argued that
a congressional appropriations rider enjoining use of funds from the DOJ prohibited the continued prosecution of his case.102
Kleinman moved to dismiss the case pursuant to California medical marijuana laws, and the state charges against him were dropped.103 Once the case was
dismissed, the DEA confiscated the evidence that was in the LAPD’s custody
and used this evidence to indict Kleinman on charges of conspiracy to distribute
and possess marijuana.104
Kleinman moved to suppress the evidence on the grounds that it was obtained with a search warrant that lacked probable cause.105 The district court

94. Id. at *7.
95. Mann, 2016 WL 6473215, at *7.
96. Id. at *8.
97. Id.
98. Id. at *9.
99. United States v. Kleinman, 880 F.3d 1020 (9th Cir. 2017), cert denied, 2018 WL
2418211 (U.S. Oct. 1, 2018).
100. Id. at 1025.
101. Id. at 1025–26.
102. Id. at 1026.
103. Id.
104. Id.
105. Kleinman, 880 F.3d at 1026.
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found that compliance with state law is not a defense to federal charges, and
Kleinman was convicted on all counts.106
Shortly after being convicted and sentenced, the appropriations rider was
enacted by Congress.107
Amongst other arguments, Kleinman asserted that “a congressional appropriations rider enjoining use of [DOJ] funds . . . prohibits continued prosecution
of his case.”108 Thus, the issue presented before the court was whether Kleinman
was entitled to remand for an evidentiary hearing on compliance with state
law.109 The court denied his motion to remand for a McIntosh hearing.110 The
court cited to McIntosh and 140 agreed that federal criminal defendants who are
indicted in marijuana cases have standing to file appeals which seek to enjoin the
DOJ’s use of funds to prosecute cases.111 However, the appropriations rider does
not prohibit prosecuting individuals for conduct that is not compliant with state
law.112 The court said that this rider did not apply to two charges against Kleinman because the alleged conduct does not fully comply with state law—
conspiracy to distribute marijuana and conspiracy to commit money laundering.113 Kleinman had no state law defense for these charges.114
Further, the court stated that the appropriations rider prohibits use of funds
in connection with a specific charge involving conduct that is fully compliant
with state laws.115 In applying the rider, the focus is on conduct forming the basis
of a particular charge, which requires an analysis to determine which charges the
rider restricts. The court also mentioned that the appropriations rider did not require the court to vacate convictions obtained before the rider took effect.116 In
this instance, Kleinman was convicted before the appropriations rider became
law.117 In addition, only the continued expenditure of funds related to the statelaw-compliant conviction after the rider took effect would be unlawful.118

106.
107.
108.
109.
110.
111.
112.
113.
114.
115.
116.
117.
118.

Id.
Id. at 1027.
Id. at 1026.
Id. at 1027.
Id. at 1029–30.
Kleinman, 880 F.3d at 1027.
Id.
Id. at 1028–29.
Id. at 1029.
Id. at 1028.
Id.
Kleinman, 880 F.3d. at 1027.
Id. at 1028.
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D. U.S. v. Daleman119
In this case, the defendant, Richard Daleman was charged with “conspiracy
to cultivate 1,000 or more marijuana plants . . . cultivation of more than 50 but
less than 100 marijuana plants . . . and possession of 100 more kilograms of marijuana with the intent to distribute.”120
Daleman negotiated the sale of 190 pounds of marijuana for over $200,000
with an undercover detective.121 A search warrant was executed which resulted
in over two thousand marijuana plants and hundreds of pounds of processed marijuana being seized.122 A federal indictment was returned.123 Daleman submitted
several motions, which were all denied.124 Daleman then submitted a motion to
enjoin the DOJ from spending funds to continue his prosecution.125 Thus, the
issue presented was whether the DOJ’s use of funds to prosecute this case violated the appropriations clause of the constitution.126
In its holding, the court denied Daleman’s motion to enjoin the expenditure
of funds by the DOJ.127 The court reasoned that prosecuting “individuals who do
not strictly comply with all state law conditions regarding the use, distribution,
possession, and cultivation of medical marijuana” does not violate the appropriations rider.128
The Ninth Circuit emphasized that at an evidentiary hearing, a defendant
must establish that he strictly complied with all conditions of state law in order
to prohibit the DOJ’s expenditure of funds.129 Daleman failed to show this.130
Even if Daleman had been effectively operating a dispensary, the negotiated sale
with the undercover detective was not in compliance with state law.131

119. United States v. Daleman, No. 1:11-CR-00385-DAD-BAM, 2017 WL 1256743
(E.D. Cal. Feb. 17, 2017).
120. Id. at *1.
121. Id.
122. Id.
123. Id.
124. Daleman, 2017 WL 1256743, at *1.
125. Id.
126. Id. at *2.
127. Id. at *2.
128. Id.
129. Id.
130. Daleman, 2017 WL 1256743, at *7.
131. Id.
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U.S. v. Nixon132

Alan Nixon, the defendant, “pled guilty to aiding and abetting the maintenance of a drug-involved premise . . . .”133 As a result, Nixon was sentenced to
probation.134 A condition of Nixon’s probation required him to “refrain from unlawful use of a controlled substance and [to] submit to periodic drug testing.”135
Nixon moved the court to modify his conditions of probation on the ground that
the appropriations rider required that he be allowed to use medical marijuana
while on probation in compliance with California’s Compassionate Use Act.136
After Nixon was sentenced, Congress enacted an appropriations rider that
prohibits the DOJ from using funds to prevent states from implementing state
laws that authorize the use, distribution, possession, or cultivation of medical
marijuana.137 The district court denied Nixon’s motion, finding that the rider had
“no effect on the court or the Probation Office . . . .”138 Nixon appealed.139
“Nixon argued that the appropriations rider suspended the [CSA]” in relation to
individuals using marijuana “in compliance with the Compassionate Use Act.”140
At issue was whether a federal district court is prohibited from restricting
the use of medical marijuana as a condition of probation as a result of a congressional appropriations rider prohibiting the DOJ from using funds to prosecute
individuals who are in compliance with state marijuana laws.141
In its holding, the court affirmed the district court’s denial of Nixon’s motion
for modification.142 The court addressed the appropriations rider in stating that
while the rider restricts the DOJ from using certain funds for prosecution, individuals still face the possibility of being prosecuted under the CSA.143 According

132. United States v. Nixon, 839 F.3d 885 (9th Cir. 2016).
133. Id. at 886.
134. Id.
135. Id.
136. Nixon, 839 F.3d at 887.
137. Id. at 886–87.
138. Id. at 887.
139. Id.
140. Id.; see Compassionate Use Act of 1996, CAL. HEALTH & SAFETY CODE § 11362.5
(1996); see also Mann v. Gullickson, No. 15-cv-03630-MEJ, 2016 WL 6473215, at *3 (N.D.
Cal. Nov. 2, 2016) (“Cal. Health & Safety Code § 11362.5 . . . gives a person who uses marijuana for medical purposes on a physician’s recommendation a defense to certain state criminal charges involving the drug, including possession.”).
141. Nixon, 839 F.3d at 886.
142. Id. at 888.
143. Id.; see also HEALTH & SAFETY § 11362.5.
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to the court, the appropriations rider does not “provide immunity from prosecution for marijuana offenses.144 The CSA prohibits the manufactur[ing], distribution, and possession of marijuana.”145 Also, the court goes on to state that no
state law legalizes marijuana manufacturing, possession, or distribution.146 In addition, “state laws cannot permit what federal law prohibits.”147
In another federal case, U.S. v. Marlin Alliance for Medical Marijuana
(MAMM), the court held that the prosecution of medical marijuana defendants
must meet the RFA.148 Consequently, the judge ruled that the DOJ could not
enforce an injunction against MAMM as it was operating in compliance with
California state law.149 That is, because the providers were acting in compliance
to state law, the DOJ could not shut down this state legal provider.150 In 2016, a
case against a massive Oakland, California medical marijuana collective was
dropped, just one year after the renewal of the RFA.151
Since these cases, especially those from the Ninth Circuit, generally support
the implementation of the RFA, the question is whether it is time to really reconsider a federal marijuana reform. Looking at the recent amendment proposed by
Senator Cory Booker may shed some light as to where the marijuana debate may
lead in relation to state and federal laws.152
V. FEDERAL MARIJUANA REFORM: A TIME TO RECONSIDER?
As stated above, the CSA of 1970 made it illegal to manufacture, distribute,
and possess marijuana, classified under the act as a Schedule 1 narcotic.153 As a
Schedule 1 narcotic, it is said to have no medical use, and therefore doctors are
not to prescribe it.154 The United States Supreme Court recognizes the power of

144. Nixon, 839 F.3d at 888.
145. Id.
146. Id.
147. Id.
148. United States v. Marin All. for Med. Marijuana, 139 F. Supp. 3d 1039, 1047–48
(N.D. Cal. 2015).
149. Id. at 1043, 1047–48.
150. See id.
151. Mollie Reilly, Feds Drop Case Against Influential Medical Marijuana Dispensary, HUFFINGTON POST (May 3, 2016, 3:26 PM), https://www.huffingtonpost.com/entry/har
borside-health-center-case-dropped_us_5728d2d1e4b016f37893a9c2 (noting though the U.S.
Attorney’s Office did not comment on the reason the case was dropped, it is speculated the
renewal of the RFA and dismissal of a similar case are to blame).
152. S. 1689, 115th Cong. (2017).
153. Erwin Chemerinsky et al., Cooperative Federalism and Marijuana Regulations,
62 UCLA L. REV. 74, 82–83 (2015).
154. Id. at 83.
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the federal government to regulate marijuana as a whole in all fifty states.155
Consequently, the growing and use of marijuana in any state may invite the scrutiny of the federal government. There have been suggestions that the DEA reschedule marijuana from a Schedule 1 classification, but this has been met with
resistance.156 This resistance has been supported by the U.S Court of Appeals for
the District of Columbia in recognizing that the refusal of the DEA to reschedule
“is not arbitrary and capricious.”157
In 1996, state marijuana policy started to shift when states began to consider
factors such as the amount of resources employed for the enforcement of the
laws, the fact that the drug was widely available and prohibition did not make
sense, the fact that there was increase support, politically and otherwise to employ medical marijuana to treat seriously ill persons.158 In consideration of this
policy shift, the state of California paved the way by becoming the first state to
allow the use of medical marijuana.159 Since then 29 other states have followed
suite with eight other states also supporting the use of recreational marijuana.160
In an attempt to resolve the impasse between state and federal treatment of
marijuana, bills have been introduced in Congress with little or no permanent
success.161 Some of the recent past proposed bills deal with issues such as:
Rescheduling marijuana to permit marijuana for medical use in those
states in which it has been legalized;162 providing an affirmative defense
for medical marijuana related activities carried out in compliance with
state law and obligate the return of property seized by the federal government in relation to marijuana prosecutions;163 prohibiting the DEA
and the DOJ from spending taxpayer money to attack, arrest or prosecute medical marijuana patients and providers in states with legalized
medical marijuana laws;164providing legal immunity from criminal
155. Id.
156. Id.
157. Id.; see also Controlled Substance Act, 21 U.S.C. § 811(a)-(b) (2015) (outlining
that under the CSA, after a formal rule making, scientific, and medical evaluation, and on
the recommendation of the secretary of Health and Human Services, the Attorney General is
authorized to transfer a drug between Schedules or remove any drug from a Schedule).
158. Chemerinsky et al., supra note 153, at 84–85.
159. Id. at 85 (“Proposition 215 permitted marijuana use by those who received an oral
or written recommendation from a doctor.”).
160. Clay Dillow, Paying taxes in cash, marijuana companies have a lot to hash out
with IRS, CNBC (Apr. 18, 2017 9:59 AM), http://www.cnbc.com/2017/04/18/marijuana-com
panies-sending-a-huge-cash-roll-to-irs-on-tax-day.html.
161. See Chemerinsky et al., supra note 153, at 113–14.
162. States’ Medical Marijuana Patient Protection Act, H.R 689, 113th Cong. (2013).
163. Truth in Trials Act, H.R 710, 113th Cong. (2013).
164. 160 CONG. REC. 1034 (2014) (statement of Hon. Alcee L. Hastings)
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prosecution to banks and credit unions that provide financial services to
marijuana-related businesses operating in compliance with state laws;165
to prohibit any provision of CSA from applying to anyone acting in
compliance with state marijuana law;166 and to amend the CSA preemption provision section 903167 to stipulate that CSA not be interpreted to
mean that Congress intended to occupy the field of marijuana enforcement or preempt state marijuana law.168
Taking a look at the recent Marijuana Justice Act of 2017, including the broad
and legitimate discussions raised by this bill, would expand our understanding of
the related issues brought to the forefront.
A. Marijuana Justice Act of 2017169
Reconsidering the marijuana trajectory, the Marijuana Justice Act of 2017
(MJA) was introduced by Senator Cory Booker of New Jersey.170 The MJA has
a provision that punishes states that overwhelmingly arrest low–income and minorities.171 This unusual proposal by Senator Booker highlights major policy issues regarding the past and future of marijuana legalization.172
1) The proposal removes marijuana from the list of controlled substances as
provided in the CSA.173 Following this proposal would undoubtedly result in the

165. Marijuana Business Access to Banking Act of 2013, HR 2652, 113th Cong. § 3
(2013).
166. Respect State Marijuana Laws Act of 2013, H.R.1523, 113th Cong. § 2 (2013).
167. 21 U.S.C. § 903 (2012) (setting out the circumstances under which CSA will
preempt state law).
168. Respect States’ and Citizens’ Right Act of 2013, H.R. 964, 113 Cong. § 2(b)
(2013).
169. Marijuana Justice Act of 2017, S. 1689, 115th Cong. (2017).
170. See Drug Policy—Marijuana Justice Act of 2017—Senator Cory Booker Introduces Act to Repair the Harms Exacted by Marijuana Prohibition.—Marijuana Justice Act of
2017, S. 1689, 115th Con. [hereinafter Drug Policy—Marijuana Justice Act of 2017], 131
HARV. L. REV. 926, 926 (2018).
171. S. 1689 § 3(b)(1).
172. See Drug Policy—Marijuana Justice Act of 2017, supra note 170, at 926.
173. See e.g., H.R. 2020, 115th Cong. § 1 (2017) (reflecting that prior bills tend to seek
to reschedule marijuana to a lower-penalized category and not outright removal like the Booker proposal).
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avoidance of federal prosecution, as well as reduce the consequences for businesses associated with marijuana legalization.174 For example, marijuana
businesses could legally have access to banking services.175
2) The MJA would allow the Attorney General to pinpoint states with disproportionate arrest and incarceration rates and reduce federal funding for the
prisons and police in those communities/states.176 That is, states that are ineligibile under this criteria due to their racial and/or class bias in arrest and incarceration practices may not receive federal funds for the construction or staffing of
their prisons or jails.177
The MJA envisioned that any savings resulting from such reductions should
be redirected to a Community Reinvestment Fund, to be managed by the Housing
and Urban Development (HUD) secretary who could distribute said savings as
grants to communities that have been impacted by drug laws.178 However, the
MJA has been criticized by a Harvard article for not going far enough in also
addressing issues relating to the profits that would result from marijuana legalization.179 The article suggest that the MJA includes provision arming the cities
and states with authority to prioritize those persons who have been hurt by the
criminalization of marijuana law to be given a first chance to acquire permits and
licenses for growing, distributing and selling marijuana.180
3) The MJA also requires that marijuana related convictions be expunged
and those civilians who have been impacted by such convictions be given a right
to sue for the harsh punishment suffered as a result.181 The MJA provides that
those currently serving a prison term involving marijuana be eligible for sentence
reduction through sentences reconsideration.182 This would reduce the harsh impact on those convicted for marijuana related violations by restoring some of
their rights realting to voting, jury service, employment, immigration and
more.183
174. Drug Policy—Marijuana Justice Act of 2017, supra note 170, at 929.
175. See generally Florence Shu-Acquaye, The Unintended Consequences to Legalizing Marijuana Use: The Banking Conundrum, 64 CLEV. STATE L. REV. 315, 324–27 (2016)
(for a detailed discussion on marijuana businesses’ access to banking services).
176. Drug Policy—Marijuana Justice Act of 2017, supra note 170, at 929.
177. Marijuana Justice Act of 2017, S. 1689, 115th Cong. § 3(a) (2017).
178. S. 1689 § 4(c); see Drug Policy—Marijuana Justice Act of 2017, supra note 170,
at 929–30; Brentin Mock, What Does Marijuana Justice Actually Look Like?, CITYLAB
(Jan. 11, 2018), http://www.citylab.com/equity/2018/01/what-does-marijuana-justice-actually
-look-like/550328/.
179. Drug Policy—Marijuana Justice Act of 2017, supra note 170, at 927, 930–31.
180. Id. at 932.
181. Id. at 930.
182. S. 1689 § 3(d).
183. See Drug Policy—Marijuana Justice Act of 2017, supra note 170, at 930.
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4) The Harvard article suggest that the MJA missed out on including tax
revenue derived from legal marijuana sales,which may have helped achieve a
level playing field in marijuana justice.184 Including the tax revenue could have
resulted in some legal marijuana sales tax to compensate those whose lives have
been shattered due to the past arrests and imprisonment for marijuana law violations.185
Although, the future of this Act seems bleak in terms of the support needed
for it to pass, it does appear to have addressed some important issues, like reducing or resentencing, but it is criticized as having failed to deal with the regulation
of the legal marijuana market to effectively achieve those goals and objectives
intended in the MJA.186 Thus, without a regulatory framework, the critic says,
the harm inherent in marijuana prohibition in reducing the racial and economic
inequality that prevails at the moment will likely continue.187 Of the over 3,000
storefront marijuana dispensaries in the United States, fewer than three dozen are
owned by black people.188 Projections that the legal marijuana market will get to
18 billion by 2020189 drives the reality home. The Harvard article aptly articulated this defect when it stated that:
Racial inequality remains a pernicious reality of current legalization efforts around the country. Black and Latino victims of the drug war are
noticeably absent from current legal marijuana markets. . . . After a long
history of pervasive discrimination in employment and education, black
and Latino Americans are far less likely to be able to raise the money
necessary to start marijuana businesses.190
Looking at the city of Oakland’s approach may be useful in this marijuana debate
on how states that legalize marijuana may consider its regulation via reparations.

184. Id. at 933.
185. Id.; Mock, supra note 178.
186. See Drug Policy—Marijuana Justice Act of 2017, supra note 170, at 930; Mock,
supra note 178.
187. Drug Policy—Marijuana Justice Act of 2017, supra note 170, at 930.
188. Id. at 931; Amanda Chicago Lewis, America’s Whites-Only Weed Boom,
BUZZFEED NEWS (Mar. 16, 2016, 10:01 PM) https://www.buzzfeednews.com/article/amanda
chicagolewis/americas-white-only-weed-boom.
189. ARCVIEW MKT. RESEARCH, THE STATE OF LEGAL MARIJUANA MARKETS: EXECUTIVE SUMMARY 3 (5th ed. 2017); Drug Policy—Marijuana Justice Act of 2017, supra note
170, at 931–32.
190. Drug Policy—Marijuana Justice Act of 2017, supra note 170, at 931.
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B. The Case of Oakland, California
On November 8, 2016, California voters passed Proposition 64, the
Adult Use of Marijuana Act legalizing the personal use of marijuana for
adults over 21, and creating a regulatory program for nonmedical cannabis.191 “These regulations included a state licensing program for commercial
nonmedical cannabis, which largely mirrored the licensing system for
medical cannabis in the Medical Cannabis Regulation and Safety Act.” 192
On the strength of Proposition 64, in May 2017, the city of Oakland “rolled
out a new permit program for cannabis businesses,” prioritizing individuals
“convicted of a marijuana charge in the city of Oakland, or who were longtime residents of neighborhoods with the highest numbers of weed-related
arrests.” 193
To increase the feasibility of the equity program, the city “earmarked $3.4
million from cannabis license tax revenue for no-interest loans and technical assistance for equity applicants.”194 Further, the city is to “issue a request for proposals to help equity applicants work on their business plans, obtain loans and
prepare their applications for a license.”195 The major hurdle faced in this new
program is that some applicants are unable to produce the required documentation demonstrating eligibility for equity status.196 However, city officials are
working to expand the acceptable documents.197
As to the effectiveness of this program, only time will tell, but there is no
doubt that giving an economic opportunity to those who had been scarred by past
marijuana violations is nothing short of a second chance to be better productive
and integrated people in their communities. Perhaps a successful implementation
of this program may serve as a model for other states and communities as they
navigate this somewhat complex marijuana legalization debate.

191. Assemb. B. 64, 2017-2018 Leg., Reg. Sess. (Cal. 2016).
192. Overview Of The California’s Cannabis Legal Systems, RINGGENBERG L. FIRM
https://www.ringgenberglaw.com/n-mcrsa-overview (last visited Mar. 23, 2018).
193. Tammerlin Drummond, A call for pot entrepreneurs, Oakland test drives new marijuana permit program, E. BAY TIMES (Aug. 1, 2017, 4:11 PM), http://www.eastbaytimes.
com/2017/07/28/a-call-for-pot-entrepreneurs-oakland-test-drives-new-cannabis-permit-pro
gram.
194. Id.
195. Id.
196. Id.
197. Id.

SHU-ACQUAYE

2018/19

12/14/2018 11:32 AM

MEDICAL MARIJUANA

149

VI. CONSEQUENCES OF CONTINUED FEDERAL PROHIBITIONS:
THE BANKING AND TAX CONUNDRUMS
A. The Banking Conundrum
Unfortunately, for many legal marijuana businesses “banking in the traditional sense is an aspiration rather than the norm.”198 This is a real problem for
an industry that is expected to boom to $21 billion by 2021.199
One major unintended consequence of the state marijuana legalization is that
marijuana businesses face the challenge of creating a bank account, or obtaining
loans, and therefore must hoard their cash, which itself is a high risk.200 As a
practical matter, the businesses are an easy target for thieves who are conversant
with the fact that these businesses have no access to banking services.201 This is
compounded by the fact that the banks could be subject to prosecution for money
laundering and anti-trafficking laws.202 Thus, banks are reluctant to extend their
services to marijuana dispensaries that operate under legal state laws.203
Although the 2014 Cole Memo from the then Attorney General Holder
seems to somewhat water down this inherent fear of prosecution by stating that
marijuana businesses should have access to banking services, it still did not alleviate the problem because the banks would still be subject to prosecution, given
no substantive change in federal drug law.204 Needless to say, the executive
branch can do very little on its own to effectuate change in curtailing the banking
restrictions on the marijuana industry.205 This is even so, given the fact that, even
if the banks were to give a carte blanch to marijuana businesses using their banking services, the CSA still remains the law of the land and therefore the assets of
the businesses could still be seized under the CSA.206

198. Dillow, supra note 160.
199. Id.
200. Id. (explaining that the lack of banking services also invariably creates innumerable logistical problems within the day-to-day operations of what are otherwise traditional
production and retail operations).
201. Chemerinsky et al., supra note 153, at 91.
202. Rosalie Winn, Hazy Future: The Impact of Federal and State Legal Dissonance
on Marijuana Businesses, 53 AM. CRIM. L. REV. 215, 217–18 (2016).
203. See id.; see also Julie Anderson Hill, Banks, Marijuana, and Federalism, 65 CASE
W. RES. L. REV. 597, 610 (2015) (discussing Federal Anti-Laundering Statutes and in particular the Money Laundering Control Act, which subjects entities and individuals to criminal
liability for money laundering).
204. See Hill, supra note 203, at 610.
205. See id. at 616–17.
206. Id. at 610.
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The 2018 Jeff Session memo explicitly undoes any attempt by the Obama
administration to alleviate the marijuana banking issue.207 The memo empowers
local federal prosecution with the discretion to “weigh all relevant considerations” in following marijuana offenders in their jurisdictions.208 This is the proverbial last nail in the coffin, dashing any hopes and indicating that the continued
risk of prosecution undermines state goals in legalization.209 Perhaps the reason
why the Colorado Banker’s Association found the guidance to be ‘“a red light’
that amounts to ‘serve customers at your own risk,’” and suggested banks should
not comply.210
The statement by Lance Perryman, founder and CEO of Next Harvest, a Marijuana company in Colorado, aptly makes the point on the issue of banking and
regulation when he stated that “[t]he lack of financial infrastructure makes it difficult for cannabis companies to establish exactly the kind of fiscal paper trail
that federal and state regulators could use to help enforce regulatory compliance.”211 Marijuana Banking will require the federal financial regulators to set
clear and achievable due diligence requirements for marijuana business
customers.
B. The Tax Conundrum
Marijuana, as earlier stated, is categorized as a Schedule I substance under
the CSA.212 Consequently, even legal marijuana businesses have to pay taxes
under IRS code 280E, the same category reserved for illegal drug traffickers.213
Although 29 states in the U.S. have legalized some form of medicinal marijuana,
and a few have passed laws allowing recreational marijuana use, those marijuana
operated businesses in those states are nonetheless violating federal law, and
therefore are subject to the consequences, including section 280E of the IRS
code.214
207. Press Release, Sessions, supra note 55.
208. Mikosra, Jeff Sessions Rescinds Obama-Era Enforcement Guidance: Five Observations, VAND. U. (Jan. 5, 2018), https://my.vanderbilt.edu/marijuanalaw/2018/01/jeffsessions-rescinds-obama-era-enforcement-guidance-six-observations/.
209. See Winn, supra note 202, at 231.
210. Id. at 231–32.
211. See Dillow, supra note 160.
212. Chermerinsky et al., supra note 153, at 82.
213. Will Yakowicz, The Sexiest Story of Taxes and Marijuana: The History of Tax
Code 280E, INC (June 29, 2016), https://www.inc.com/will-yakowicz/how-cpas-tax-lawyersfighting-irs-for-marijuana.html.
214. Harborside Health Ctr., Fighting the Feds, Round Two: Harborside vs. the IRS,
GLOBE NEWS WIRE (June 4, 2016, 11: 31 AM), http://globenewswire.com/news-release/2016
/06/04/846107/10163270/en/Fighting-the-Feds-Round-Two-Harborside-vs-the-IRS.html.
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Under Federal Tax Rule 280E, any trade or business that is carried out in
violation of federal drug law will pay federal income tax under less favorable
conditions.215 Section 280E prohibits drug trafficking organizations (DTOs)
from “taking the normal and necessary deductions allowed to all other businesses . . . including expenses for labor, rent, utilities, insurance, professional
fees,” and more.216 When applicable, “[t]he IRS application of Section 280E to
medical cannabis businesses can result in a very high federal tax rate of 60 to 90
percent,” which is said to be greater than their margin of profit in many cases.217
In other words, a marijuana seller’s income is overtaxed.
This 280E rule was tested in the long and outdrawn case between the IRS
and Harborside Health Center of Oakland, California.218 Harborside Health Center is a nonprofit medical-marijuana dispensary.219 The Center’s Oakland branch
was audited by IRS in 2010.220 Although the IRS found “Harborside’s financial
records to be in order, the IRS [still] slapped the center with a back-tax bill to the
tune of $2.4 million.”221 The IRS alleged that the Center was precluded from
legally claiming many of the deductions and expenses because of section
280E.222 The IRS alleged, as a marijuana business, under 280E, the Center was
barred from the “normal and necessary” deductions that are otherwise allowed
for any other kind of business.223 In June 2016, the Center tried to get the IRS to
drop the back pay charges of $2.4 million.224 The Center’s lead attorney stated
that the intent of Congress when the Act was passed is not being met today, because “Section 280E was passed during the height of the War on Drugs, many
years before California and 24 other states legalized the use of medical
cannabis.”225 He also said the Act was meant to apply to “drug dealers, not state-

215. I.R.C. § 280E (2012). (“No deduction or credit shall be allowed for any amount
paid or incurred during the taxable year in carrying on any trade or business if such trade or
business, or the activities which comprise such trade or business, consists of trafficking in
controlled substances, within the meaning of Schedule I and II of the Controlled Substances
Act, which is prohibited by federal law or the law of any state in which such trade or business
is conducted.”).
216. Harborside Health Ctr., supra note 214.
217. Id.
218. Id.
219. See id.
220. Id.
221. Guillermo Jimenez, Historic Ruling in Legal Marijuana vs. IRS Could Be Just
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sanctioned cannabis dispensaries” and “[i]gnoring the intent of Congress, the
IRS has chosen to apply 280E to legitimate cannabis businesses.”226 So, while
the outcome of the decision is pending, it is bound to send a decisive message to
state businesses regardless of the outcome.
In the interim, Pete Stark (D-CA) the original sponsor of Section 280E, has
vehemently requested in public that state-legal marijuana businesses be excluded
from the applicability of 280E.227 Stark says that the IRS’s interpretation of section 280E “undercuts legal medical marijuana dispensaries by preventing them
from taking the full range of deductions allowed for other small businesses . . .
[and] punishes the thousands of patients who rely on them for safe, legal, reliable
access to medical marijuana as recommended by a doctor.”228
Like removing marijuana classification from Schedule 1 of the CSA, it
would be difficult to reverse the applicability of 208E on businesses classified as
marijuana businesses under the CSA. However, only time and the forthcoming
Harborside decision will tell whether United States tax authorities will treat medical cannabis as a legitimate enterprise or still as illicit drug trafficking.
VII. ISSUES WITH A FEDERAL MARIJUANA REFORM
Although the DOJ non-enforcement policy does not really seem to stop
states from legalizing marijuana per se, it is only an interim solution because the
policy could easily be changed from one administration to the next, as seen with
the recent Sessions memo.229
Operating a marijuana business under the guise that the federal government
would not go after the business entity or individual because of a guidance memo
is relying only on a short-term fix.230 Even if the DOJ non-enforcement policy
was to protect marijuana business from federal criminal prosecution, the current
conflict between state and federal law does not just disappear.231 For example, a
marijuana business operating in a state that has legalized marijuana does not automatically have access to banking services.232
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The guidance Policy Memo does not empower banks to deal with the marijuana business. On the contrary, the banks, if they were to transact business with
that marijuana business entity or individual, will be running afoul of other federal
banking laws.233
In the same vein, steep penalties would apply to marijuana businesses under
Rule 280E, regardless of whether a guidance memo was in favor of operating the
business under state law.234 The longer the federal government abstains from
getting involved in the prosecution of marijuana businesses because of a policy
memo, the more permanent the policy becomes, as it may simply just continue
in perpetuity. This indefinite non-enforcement scenario would tantamount to the
executive branch exceeding its proper role as it effectively suspends a federal
statute, thereby encroaching into the constitutional role of Congress.235
Lastly, issues arise when federal marijuana laws are not applied consistently
in the same manner in all the states resulting in citizens of states who have not
legalized marijuana being subjected to incarceration, while citizens in states that
have legalized it could be making millions by engaging in the same activity.236
These issues show undoubtedly that the DOJ memos are nothing but a temporary fix to the state and federal marijuana conflict. Perhaps this is why other
suggestions on how to resolve this state federal conflict have been made and
pursued, including:
1) Preventing the DOJ from spending money to interfere with state marijuana laws; 2) providing an affirmative defense based on compliance
with state marijuana laws; 3) allowing states to opt out of federal marijuana provisions; and 4) ending the federal ban on marijuana and replacing it with some sort of federal regulatory structure. 237
Each of these options undoubtedly have pros and cons, but taking these options into consideration in moving forward in the marijuana state and federal
debate is better than doing nothing.

regulations create mess for marijuana industry, banks, and law enforcement, OR. LIVE
(Apr. 20, 2018), https://www.oregonlive.com/opinion/index.ssf/2018/04/banking_regulations
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CONCLUSION
The pertinent question in the marijuana industry is what marijuana businesses should currently expect in terms of prosecution under federal law, given
that on January 4, 2018, Attorney General Sessions rescinded the Cole Memo.238
Perhaps the industry should be comforted by the facts that U.S. Attorneys have
the discretion to determine which marijuana operations to prosecute.239 How this
will unfold, will only be seen with the passing of time.
Case law, U.S vs. McIntosh in particular, has held that the Rohrabacher-Farr
Amendment prevents federal prosecution of conduct that is in compliance with
state marijuana laws.240 The court emphasized that medical marijuana is still illegal under the CSA and remains the law of the land and the decision of the court
really does not change this underlying law.241
The 2017 Act, on the other hand, has some interesting and innovative issues
presented that could be feasible in addressing the legality of marijuana businesses
and federal law, but however fails to provide a regulatory framework and as such
leaves a vacuum. The question remains, what is left to deal with this state-federal
impasse?
Change in federal marijuana law does not appear to be imminent, but it is
inevitable. With 29 states already having some form of marijuana legislation and
with that seeming plausible for others, federal marijuana prohibitions days are
short-lived. The tides will change, it is just a matter of time. If the ultimate goal
is to address the state and federal law conflict, Congress cannot continue to turn
a blind eye, but rather simply remove marijuana from the CSA, and proceed to
regulate the market. On the other hand, Congress could completely do away with
federal marijuana prohibitions, while giving the states the option to prohibit it.
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